Cargando…
Ghrelin and Cardiovascular Diseases
Ghrelin, a newly discovered bioactive peptide, is a natural endogenous ligand of the growth hormone (GH) secretagogue receptor and initially identified as a strong stimulant for the release of GH. Subsequent research has shown that ghrelin and its various receptors are ubiquitous in many other organ...
Autores principales: | Zhang, Gaigai, Yin, Xinhua, Qi, Yongfen, Pendyala, Lakshmana, Chen, Jack, Hou, Dongming, Tang, Chaoshu |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers Ltd.
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2845796/ https://www.ncbi.nlm.nih.gov/pubmed/21286280 http://dx.doi.org/10.2174/157340310790231662 |
Ejemplares similares
-
Cellular Cardiomyoplasty and Cardiac Regeneration
por: Pendyala, Lakshmana, et al.
Publicado: (2008) -
Research progress of ghrelin on cardiovascular disease
por: Yuan, Ming-Jie, et al.
Publicado: (2021) -
Metabolic and Cardiovascular Effects of Ghrelin
por: Tesauro, Manfredi, et al.
Publicado: (2010) -
Survival bias and drug interaction can attenuate cross-sectional case-control comparisons of genes with health outcomes. An example of the kinesin-like protein 6 (KIF6) Trp719Arg polymorphism and coronary heart disease
por: Williams, Paul, et al.
Publicado: (2011) -
Effect of Ghrelin on the Cardiovascular System
por: Hosoda, Hiroshi
Publicado: (2022)